White House Denies Trump Was Early Recipient of Experimental Weight Loss Drug
White House officials have denied reports that President Donald Trump received early access to an experimental weight loss drug, retatrutide. A STAT report indicated a 79-year-old patient was granted access via "compassionate use," sparking speculation due to the patient's age matching Trump's at the time.

















